{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:39:14Z","timestamp":1794242354749,"version":"4.9.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00428-022-03281-z","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:03:11Z","timestamp":1642550591000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma?"],"prefix":"10.1007","volume":"481","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7618-1379","authenticated-orcid":false,"given":"Megumi","family":"Nishikubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-3568","authenticated-orcid":false,"given":"Naoe","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Tachihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Maniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"3281_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591\u20131603. https:\/\/doi.org\/10.1056\/NEJMra050152","journal-title":"N Engl J Med"},{"key":"3281_CR2","first-page":"151","volume":"9","author":"D Whitaker","year":"1992","unstructured":"Whitaker D, Henderson DW, Shilkin KB (1992) The concept of mesothelioma in situ: implications for diagnosis and histogenesis. Semin Diagn Pathol 9:151\u2013161","journal-title":"Semin Diagn Pathol"},{"key":"3281_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","volume":"136","author":"A Churg","year":"2012","unstructured":"Churg A, Galateau-Salle F (2012) The separation of benign and malignant mesothelial proliferations. Arch Pathol Lab Med 136:1217\u20131226. https:\/\/doi.org\/10.5858\/arpa.2012-0112-RA","journal-title":"Arch Pathol Lab Med"},{"key":"3281_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.pathol.2020.12.005","volume":"53","author":"S Klebe","year":"2021","unstructured":"Klebe S, Nakatani Y, Dobra K, Butnor KJ, Roden AC, Nicholson AG, Marchevsky AM, Husain AN, Segal A, Walts AE, Weynand B, Michael CW, Dacic S, Godbolt D, Attanoos R, Santoni-Rugiu E, Galateau-Salle F, Hiroshima K, Moreira AL, Burn J, Nabeshima K, Gibbs AR, Churg A, Litzky LA, Brcic L, Tsao MS, Mino-Kenudson M, R\u00f8rvig SB, Tazelaar HD, Krausz T, Zhang YZ, Chirieac LR, Beasley MB, Hjerpe A (2021) The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis. Pathology 53:446\u2013453. https:\/\/doi.org\/10.1016\/j.pathol.2020.12.005","journal-title":"Pathology"},{"key":"3281_CR5","unstructured":"WHO Classification of Tumours Editorial Board (2021) Thoracic tumours, WHO classification of tumours, 5th edn. International Agency for Research on Cancer, Lyon"},{"key":"3281_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","volume":"33","author":"A Churg","year":"2020","unstructured":"Churg A, Galateau-Salle F, Roden AC, Attanoos R, von der Thusen JH, Tsao MS, Chang N, De Perrot M, Dacic S (2020) Malignant mesothelioma in situ: morphologic features and clinical outcome. Mod Pathol 33:297\u2013302. https:\/\/doi.org\/10.1038\/s41379-019-0347-0","journal-title":"Mod Pathol"},{"key":"3281_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/his.13468","volume":"72","author":"A Churg","year":"2018","unstructured":"Churg A, Hwang H, Tan L, Qing G, Taher A, Tong A, Bilawich AM, Dacic S (2018) Malignant mesothelioma in situ. Histopathology 72:1033\u20131038. https:\/\/doi.org\/10.1111\/his.13468","journal-title":"Histopathology"},{"key":"3281_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000509886","volume":"65","author":"S Haefliger","year":"2021","unstructured":"Haefliger S, Savice Prince S, Rebetez J, Borer H, Bubendorf L (2021) Putative malignant pleural mesothelioma in situ (MPMIS) with sequential acquisition of genomic alterations on fluorescence in situ hybridization (FISH) examination. Acta Cytol 65:99\u2013104. https:\/\/doi.org\/10.1159\/000509886","journal-title":"Acta Cytol"},{"key":"3281_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/pin.13021","volume":"70","author":"K Hidaka","year":"2020","unstructured":"Hidaka K, Takeda T, Kinoshita Y, Nabeshima K, Tamiya S, Yoshikawa Y, Tsujimura T (2020) Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years. Pathol Int 70:1009\u20131014. https:\/\/doi.org\/10.1111\/pin.13021","journal-title":"Pathol Int"},{"key":"3281_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00428-019-02674-x","volume":"476","author":"K Minami","year":"2020","unstructured":"Minami K, Jimbo N, Tanaka Y, Hokka D, Miyamoto Y, Itoh T, Maniwa Y (2020) Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report. Virchows Arch 476:469\u2013473. https:\/\/doi.org\/10.1007\/s00428-019-02674-x","journal-title":"Virchows Arch"},{"key":"3281_CR11","first-page":"2108","volume":"9","author":"PB Illei","year":"2003","unstructured":"Illei PB, Rusch VW, Zakowski MF, Ladanyi M (2003) Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res 9:2108\u20132113","journal-title":"Clin Cancer Res"},{"key":"3281_CR12","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","volume":"44","author":"A Churg","year":"2020","unstructured":"Churg A, Naso JR (2020) The separation of benign and malignant mesothelial proliferations: new markers and how to use them. Am J Surg Pathol 44:e100\u2013e112. https:\/\/doi.org\/10.1097\/PAS.0000000000001565","journal-title":"Am J Surg Pathol"},{"key":"3281_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","volume":"453","author":"S Dacic","year":"2008","unstructured":"Dacic S, Kothmaier H, Land S, Shuai Y, Halbwedl I, Morbini P, Murer B, Comin C, Galateau-Salle F, Demirag F, Zeren H, Attanoos R, Gibbs A, Cagle P, Popper H (2008) Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch 453:627\u2013635. https:\/\/doi.org\/10.1007\/s00428-008-0689-3","journal-title":"Virchows Arch"},{"key":"3281_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.lungcan.2016.07.011","volume":"99","author":"M Hamasaki","year":"2016","unstructured":"Hamasaki M, Matsumoto S, Abe S, Hamatake D, Kamei T, Hiroshima K, Kawahara K, Sato A, Tsujimura T, Nakatani Y, Yoshida Y, Iwasaki A, Nabeshima K (2016) Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. Lung Cancer 99:155\u2013161. https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.011","journal-title":"Lung Cancer"},{"key":"3281_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M, International Mesothelioma Interest Group (2013) Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 137:647\u2013667. https:\/\/doi.org\/10.5858\/arpa.2012-0214-OA","journal-title":"Arch Pathol Lab Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03281-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03281-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03281-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T08:08:13Z","timestamp":1659341293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03281-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3281"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03281-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}